Detection of CK-19 mRNA positive CTCs, isolated with a size -based microfluidics platform, in NSCLC patients under osimertinib therapy

被引:0
|
作者
Ntzifa, Aliki [1 ]
Kotsakis, Athanasios [2 ]
Georgoulias, Vassilis [2 ]
Lianidou, Evi [1 ]
机构
[1] Univ Athens, Athens, Greece
[2] HORG, Athens, Greece
关键词
D O I
10.1158/1538-7445.AM2019-2237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2237
引用
收藏
页数:2
相关论文
共 35 条
  • [1] Detection of HER2 and CK-19 mRNA-positive circulating tumor cells (CTCs) in the peripheral blood of patients with early stage breast cancer
    Mavroudis, D.
    Apostolaki, S.
    Perraki, M.
    Politaki, E.
    Xenidis, N.
    Stathopoulou, A.
    Lianidou, E.
    Georgoulias, V.
    ANNALS OF ONCOLOGY, 2006, 17 : 93 - 93
  • [2] Detection of HER2 and CK-19 mRNA-positive circulating tumor cells (CTCs) in the peripheral blood of patients with early stage breast cancer.
    Mavroudis, D.
    Apostolaki, S.
    Perraki, M.
    Politaki, E.
    Xenidis, N.
    Stathopoulou, A.
    Lianidou, E.
    Georgoulias, V.
    CANCER RESEARCH, 2006, 66 (08)
  • [3] Detection and monitoring of circulating tumor cells (CTCs) by CK-19 mRNA in breast cancer patients treated with neoadjuvant chemotherapy: a marker of early recurrence.
    Harris, LN
    Solomon, N
    Roberts, L
    Ngo, T
    Rand, RA
    Gioioso, C
    Kuter, I
    Smith, B
    Iglehart, JD
    Friedman, P
    Taghian, A
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S46 - S46
  • [4] Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes
    Stathopoulos, EN
    Sanidas, E
    Kafousi, M
    Mavroudis, D
    Askoxylakis, J
    Bozionelou, V
    Perraki, M
    Tsiftsis, D
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 240 - 246
  • [5] Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and Immunohistochemically negative axillary lymph nodes
    Stathopoulos, E. N.
    Sanidas, E.
    Kafoussi, M.
    Mavroudis, D.
    Askoxylakis, J.
    Biozionelou, V.
    Perraki, M.
    Delidis, G.
    Tsiftsis, D.
    Georgoulias, V.
    ANNALS OF ONCOLOGY, 2004, 15 : 59 - 59
  • [7] Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer
    Georgoulias, V.
    Apostolaki, S.
    Bozionelou, V.
    Politaki, E.
    Perraki, M.
    Georgoulia, N.
    Kalbakis, K.
    Kotsakis, A.
    Xyrafas, A.
    Agelaki, S.
    Mavroudis, D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1217 - 1225
  • [8] Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer
    V. Georgoulias
    S. Apostolaki
    V. Bozionelou
    E. Politaki
    M. Perraki
    N. Georgoulia
    K. Kalbakis
    A. Kotsakis
    A. Xyrafas
    S. Agelaki
    D. Mavroudis
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1217 - 1225
  • [9] Evaluation of a novel Cytokeratin-19 (CK-19) Quantification kit for the detection of circulating tumor cells (CTCs) in peripheral blood of early breast cancer patients
    Strati, Areti
    Markou, Athina
    Stathopoulou, Aliki
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Lianidou, Evi
    CANCER RESEARCH, 2009, 69
  • [10] Trastuzumab versus observation in women with early breast cancer and CK-19 mRNA-positive circulating tumor cells (CTCs): A pilot randomized phase II study.
    Georgoulias, V.
    Bozionelou, V.
    Agelaki, S.
    Perraki, M.
    Apostolaki, S.
    Kallergi, G.
    Kalbakis, K.
    Androulakis, N. E.
    Xyrafas, A.
    Mavroudis, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)